Irène Brigger

4.8k citations

11 papers · 3.7k indexed · 2 hit papers · h-index 10

Impact in

Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems

Papers in

Biomaterials 6
- Nanoparticle-Based Drug Delivery 6
Pharmaceutical Science 1

Co-authors: Patrick Couvreur Catherine Dubernet Geneviève Aubert Jackie Morizet Gilles Vassal Marie‐José Terrier‐Lacombe Hélène Chacun Pierre Chaminade
Journals: Pharmaceutical Research (2 papers)Advanced Drug Delivery Reviews (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of Vascular Research (1 paper)International Journal of Pharmaceutics (1 paper)
Partner nations: France Switzerland Belgium

In The Last Decade

Irène Brigger

11 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Nanoparticles in cancer therapy and diagnosis 2012 · 687 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Advanced Drug Delivery Reviews
2002 Advanced Drug Delivery Reviews

Peers

Countries citing papers authored by Irène Brigger

Since Specialization

Citations

This map shows the geographic impact of Irène Brigger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irène Brigger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irène Brigger more than expected).

Fields of papers citing papers by Irène Brigger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irène Brigger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irène Brigger. The network helps show where Irène Brigger may publish in the future.

Co-authors

The 25 scholars most cited alongside Irène Brigger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Irène Brigger Line = papers co-authored together Irène Brigger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work
1	Nanoparticles in cancer therapy and diagnosis Advanced Drug Delivery Reviews ·Irène Brigger, Catherine Dubernet, Patrick Couvreur Hit paper breakdown →	2012	687
2	Evaluation of Matrix Metalloproteinases in Atherosclerosis Using a Novel Noninvasive Imaging Approach Arteriosclerosis Thrombosis and Vascular Biology ·Eric Lancelot, Vardan Amirbekian, Irène Brigger, J. Raynaud, Sébastien Ballet, Christelle David, Olivier Rousseaux, Soizic Le Greneur, Marc Port, Henri Roger Lijnen, Patrick Bruneval, Jean‐Baptiste Michel, Tanja Ouimet, Bernárd P. Roques, Smbat Amirbekian, Fabien Hyafil, Esad Vucic, Juan Gilberto S. Aguinaldo, Claire Corot, Zahi A. Fayad	2008	100
3	Magnetic Resonance Imaging of Ruptured Plaques in the Rabbit with Ultrasmall Superparamagnetic Particles of Iron Oxide Journal of Vascular Research ·Éric Durand, J. Raynaud, Patrick Bruneval, Irène Brigger, Ayman Al Haj Zen, Chantal Mandet, Eric Lancelot, Antoine Lafont	2007	21
4	CMR 2005: 4.03: A new contrast agent for magnetic resonance imaging of the vascular walls Contrast Media & Molecular Imaging ·Frédéric Chaubet, Emmanuelle Canet‐Soulas, Linda Chaabane, Deepali Pavagadhi, Irène Brigger, Claire Corot, Didier Letourneur	2006	1
5	Negative preclinical results with stealth® nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model Journal of Controlled Release ·Irène Brigger, Jackie Morizet, Chun-Yuan Chen, Geneviève Aubert, Martine Appel, Valérie Velasco, Marie-Josée Terrier-Lacombe, Didier Desmaële, Jean d’Angelo, Patrick Couvreur, Gilles Vassal	2004	76
6	The Stenlying Effect of High Hydrostatic Pressure on Thermally and Hydrolytically Labile Nanosized Carriers Pharmaceutical Research ·Irène Brigger, Laurence Armand-Lefèvre, Pierre Chaminade, Madeleine Besnard, Catalina Irene Nevarez Burgueño, Alain Largeteau, Antoine Andremont, L. Grislain, G. Demazeau, Patrick Couvreur	2003	16
7	Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting Journal of Pharmacology and Experimental Therapeutics ·Irène Brigger, Jackie Morizet, Geneviève Aubert, Hélène Chacun, Marie‐José Terrier‐Lacombe, Patrick Couvreur, Gilles Vassal	2002	181
8	Nanoparticles in cancer therapy and diagnosis Advanced Drug Delivery Reviews ·Irène Brigger, Catherine Dubernet, Patrick Couvreur Hit paper breakdown →	2002	2415
9	PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases Journal of Neuroscience Methods ·Pilar Calvo, Bruno Gouritin, Irène Brigger, Corinne Ida Lasmézas, Jean‐Philippe Deslys, Steven Williams, J.P. Andreux, Dominique Dormont, Patrick Couvreur	2001	92
10	Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation International Journal of Pharmaceutics ·Irène Brigger, Pierre Chaminade, Véronique Marsaud, M. Appel, M. Besnard, Robert Gurny, Michel Renoir, Patrick Couvreur	2001	70
11	Near Infrared with Principal Component Analysis as a Novel Analytical Approach for Nanoparticle Technology Pharmaceutical Research ·Irène Brigger, Pierre Chaminade, Didier Desmaële, Maria Teresa Peracchia, Barbara V. Howard, Robert Gurny, Michel Renoir, Patrick Couvreur	2000	44

About Irène Brigger

Irène Brigger is a scholar working on Biomaterials, Pharmaceutical Science, Surfaces, Coatings and Films, Biotechnology and Analytical Chemistry, having authored 11 papers that have together received 3.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (4 papers), RNA Interference and Gene Delivery (3 papers), Coronary Interventions and Diagnostics (2 papers), Cerebrovascular and Carotid Artery Diseases (2 papers), MRI in cancer diagnosis (1 paper), Prion Diseases and Protein Misfolding (1 paper) and Microbial Inactivation Methods (1 paper). The work is most often cited by research in Biomaterials (2.1k citations), Pharmaceutical Science (549 citations), Biomedical Engineering (1.5k citations), Molecular Medicine (163 citations) and Surfaces, Coatings and Films (144 citations). Irène Brigger has collaborated with scholars based in France, Switzerland and Belgium. Frequent co-authors include Patrick Couvreur, Catherine Dubernet, Geneviève Aubert, Jackie Morizet, Gilles Vassal, Marie‐José Terrier‐Lacombe, Hélène Chacun, Pierre Chaminade, Robert Gurny and Michel Renoir. Their work appears in journals such as Pharmaceutical Research, Advanced Drug Delivery Reviews, Journal of Pharmacology and Experimental Therapeutics, Journal of Vascular Research and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact